Direct economic impact of pharmacist’s interventions in emergency department: A prospective study in a lowermiddle income country

• Autores: Amal Mrani Alaoui, Naoufel Madani, Jihane Belayachi, Jamal Taoufik, Redouane Abouqal, Aicha Chaib
• Localización: European journal of clinical pharmacy: atención farmacéutica, ISSN 2385-409X, Vol. 23, Nº. 1, 2021, págs. 14-20
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Context: Clinical pharmacy services employ the pharmacotherapeutic expertise to ensure optimal patient outcomes and can improve the quality, safety and efficiency of care.

    Objective: The aim of the study is to measure the direct economic impact of pharmaceutical interventions issued during the analysis of prescriptions in a Moroccan medical emergency department.

    Method: The prospective study was conducted over a period of eight months in the Medical Emergency Department of Ibn sina University Hospital in Rabat, Morocco.

    The direct drug cost-savings were assessed from the point of view of the hospital center.

    Pharmaceutical Interventions (PI) with a potential direct economic impact were selected. The total direct drug cost-savings was calculated according to the hypothesis of a single day impacted. The ratio of cost-savings to induced costs was calculated as well as the return on investment.

    Results: Of the 304 pharmaceutical interventions, 113 were selected for economic impact assessment. Direct drug cost-savings during the study period was determined to be 926.51 USD in a single day impacted and a return on investment of 822.4% was found. Cost savings/induced costs ratio was 9.22. Dose adjustment saved 396.93 USD and treatment discontinuation saved 350.42 USD per one day impacted.

    Conclusion: A beneficial effect of having a clinical pharmacist involved in patient care in the emergency department was observed in our study, based on the number of accepted pharmacist interventions and the potential cost avoidance